Wiley Blackwell

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Brennan
    Brennan
  3. Motzer
    Motzer
  4. Shah
    Shah
  5. Danishefsky
    Danishefsky
  6. Russo
    Russo
  7. Shaha
    Shaha
  8. Vickers
    Vickers
  9. Eastham
    Eastham
  10. Scardino
    Scardino

Groups

  1. Department of Medicine (1524)
  2. Surgery (1238)
  3. Solid Tumor Oncology Division (886)
  4. Survivorship Research (815)
  5. GSK Faculty (669)
  6. Population Sciences Research Program (618)
  7. Sloan Kettering Institute Faculty (611)
  8. Department of Pathology and Laboratory Medicine (544)
  9. Epidemiology and Biostatistics (488)
  10. Center for Hematologic Malignancies (434)
Search Within
Formats
  1. Journal Article (3508)
  2. Meeting Abstract (680)
  3. Review (196)
  4. Book Section (106)
  5. Conference Paper (94)
  6. Editorial (90)
  7. Research Letter (35)
  8. Guidelines (28)
  9. Correspondence (25)
  10. Miscellaneous (5)
  11. Book Whole (3)
Groups
  1. Department of Medicine (1524)
  2. Surgery (1238)
  3. Solid Tumor Oncology Division (886)
  4. Survivorship Research (815)
  5. GSK Faculty (669)
  6. Population Sciences Research Program (618)

More Groups

People
  1. Harry Herr (91)
  2. Murray Brennan (86)
  3. Robert Motzer (86)
  4. Jatin Shah (77)
  5. Samuel Danishefsky (74)
  6. Andrew Vickers (71)

More People

Years
  1. 2025 (115)
  2. 2024 (192)
  3. 2023 (261)
  4. 2022 (186)
  5. 2021 (221)
  6. 2020 (183)

More Years

Publications
  1. Cancer (1455)
  2. Journal of Surgical Oncology (374)
  3. BJU International (334)
  4. Hematological Oncology (199)
  5. Histopathology (158)
  6. EMBO Journal (131)

More Publications

Results (4770)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II study of CHOEP plus lenalidomide as initial therapy for patients with stage II‐IV peripheral T‐cell lymphoma: Phase II results
    Meeting Abstract

    Lunning, M.; Horwitz, S.; Advani, R.; Vose, J.; Lee, H.; Mehta‐Shah, N.; Zain, J.; Haverkos, B.; Lechowicz, M.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Sarraf Yazdy, M.; Roeker, L.; Gashonia, L.; Goodfriend, J.; Narkhede, M.; Rhodes, J.; Kennard, K.; Morse, H.; Dorsey, C.; Battiato, K.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of 180 patients with indolent lymphomas treated with very low dose (4 Gy) radiation therapy alone
    Meeting Abstract

    Chau, K. W.; Imber, B. S.; Joffe, E.; Yang, J. C.; Chelius, M. R.; Doyle, C. J.; Hajj, C.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • WhiMSICAL (Waldenström Macroglobulinemia Study Involving CArt-wheeL): A global patient‐derived data registry mapping treatment and quality of life
    Meeting Abstract

    Tohidi‐Esfahani, I.; Warden, A.; Malunis, E.; DeNardis, P.; Bomsztyk, J.; D'Sa, S.; Kersten, M.; Palomba, M.; Spearing, R.; Thomas, S.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Patient‐reported outcomes (PROs) in Waldenström macroglobulinemia (WM) patients treated with ibrutinib‐rituximab in the iNNOVATE study
    Meeting Abstract

    Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; García‐Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L. T.; Tam, C. S.; Varettoni, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation
    Meeting Abstract

    Batlevi, C. L.; Palomba, M. L.; Park, J.; Mead, E.; Santomasso, B.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R.; Yang, J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Ibrutinib for the treatment of Bing‐Neel syndrome: A retrospective, multicenter study
    Meeting Abstract

    Castillo, J.; Itchaki, G.; Paludo, J.; Varettoni, M.; Buske, C.; Eyre, T.; Chavez, J.; Shain, K.; Issa, S.; Palomba, L.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Ibrutinib monotherapy produces long‐term disease control in previously treated Waldenstrom's macroglobulinemia. Final report of the pivotal trial (NCT01614821)
    Meeting Abstract

    Treon, S. P.; Meid, K.; Gustine, J.; Yang, G.; Xu, L.; Patterson, C. J.; Ghobrial, I.; Laubach, J. P.; Hunter, Z. R.; Dubeau, T.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • EZH2 gain‐of‐function mutations are not associated with more favorable prognosis in relapsed/refractory follicular lymphoma (FL): A preliminary analysis on 590 patients
    Meeting Abstract

    Okosun, J.; Bödör, C.; Batlevi, C.; Nagy, N.; Michot, J.; Schneider, T.; Alizadeh, H.; Simon, Z.; Vose, J.; Younes, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save